YTE reported $235.41M in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -15.3M 28.41M
Agios Pharmaceuticals AGIO:US $ -89.16M 0.07M
Alnylam Pharmaceuticals ALNY:US $ -181.68M 35.52M
Amgen AMGN:US $ 2378M 1550M
Biocryst Pharmaceuticals BCRX:US $ -44.58M 15M
Biogen BIIB:US $ 794M 308.3M
Biomarin Pharmaceutical BMRN:US $ -53.22M 64.89M
Bluebird Bio BLUE:US $ -216.95M 23.88M
Bristol Myers Squibb BMY:US $ 1996M 281M
Cerulean Pharma CERU:US $ -12668940 3.51M
Chemocentryx CCXI:US $ -21.8M 16.93M
Clovis Oncology CLVS:US $ -57.46M 0.12M
Cti Biopharma CTIC:US $ -23.38M 3.88M
Eli Lilly And LLY:US $ 1476M 72.6M
Exelixis EXEL:US $ 51.62M 71.39M
Gilead Sciences GILD:US $ 3842M 1596M
Gw Pharmaceuticals GWPH:US $ -21.03M 1.78M
Idera Pharmaceuticals IDRA:US $ -5.97M 1.59M
Intercept Pharmaceuticals ICPT:US $ 10.29M 9.53M
IONIS PHARMACEUT IONS:US $ -86M 4.4M
Macrogenics MGNX:US $ -52987000 12.71M
Merk MRK:US $ 4826M 3212M
Mirati Therapeutics MRTX:US $ -79.5M 84.69M
Moderna Inc MRNA:US 3.56B 496M
Nektar Therapeutics NKTR:US $ -113.6M 3.39M
Neurocrine Biosciences NBIX:US $ 44.5M 18.3M
Newlink Genetics NLNK:US -7497000 1.17M
Novartis NOVN:VX 3.23B 246M
Novartis NVS:US $ 3233M 246M
Pfizer PFE:US $ 7647M 1733M
Ptc Therapeutics PTCT:US $ -93.08M 5.42M
Puma Biotechnology PBYI:US $ -41.6M 39.87M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Sarepta Therapeutics SRPT:US $ -38.95M 128.63M
Seattle Genetics SGEN:US $ -297.96M 208.36M
Ultragenyx Pharmaceutical RARE:US $ -89.83M 7.05M
Vertex Pharmaceuticals VRTX:US $ 1054.51M 1092.47M
YTE INCY:US $ 235.41M 94.57M